Investment Banking
Private Placement, Merger, Acquisition and Reorganization
Investment Management
Haoyue China Healthcare Fund
Capital empowers the success of healthcare companies
Sectors
  • Biopharma
  • Medical Devices
  • Healthcare Services & Digital Health
  • IVD & Life Science
Round
  • Series A funding
  • Series B funding
  • Series C funding
  • Series D funding
  • Series E funding
  • Series F funding
  • Pre-IPO
  • Strategic Financing
  • Crossover
  • Others
Year
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
{{dealInfo.EXT2}} · {{dealInfo.EXT3}}
{{dealInfo.DESCRIPTION}}
Detail
Our breadth and depth of industry reseach capabilities enable us to produce differentiated insights with a 360-degree view of China’s healthcare industry.
关注胃肠道健康——益生菌千亿市场2025年赛道去往何方?
IVD与生命科学TOP15|产业巨头群雄逐鹿,内卷之下路在何方?|HaoYue.Insight
国产医疗器械TOP 15|历经冰火,孰能淬炼成金?|HaoYue.Insight